Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

[Frequency of hypertension resistant to treatment and indication for renal denervation].

Rosenbaum D, Villeneuve F, Gury C, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):229-33. doi: 10.1016/j.ancard.2012.04.018. Epub 2012 May 15. French.

PMID:
22677181
2.

[Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].

Villeneuve F, Rosenbaum D, Gury C, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):198-202. doi: 10.1016/j.ancard.2012.04.022. Epub 2012 May 23. French.

PMID:
22677179
3.

[Renal artery denervation for treating refractory hypertension].

Benamer H, Louvard Y, Garot P, Unterseeh T, Hovasse T, Lefèvre T, Chevalier B, Morice MC.

Ann Cardiol Angeiol (Paris). 2011 Dec;60(6):354-60. doi: 10.1016/j.ancard.2011.09.005. Epub 2011 Oct 14. French.

PMID:
22040858
4.

Renal denervation in moderate treatment-resistant hypertension.

Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.

J Am Coll Cardiol. 2013 Nov 12;62(20):1880-6. doi: 10.1016/j.jacc.2013.06.023. Epub 2013 Jul 10.

5.

[Renal denervation a treatment for resistant hypertension: a French experience].

Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC; ICV-GVM la Roseraie.

Ann Cardiol Angeiol (Paris). 2013 Dec;62(6):384-91. doi: 10.1016/j.ancard.2013.09.003. Epub 2013 Oct 12. French.

PMID:
24182849
6.

Uncontrolled hypertension based on morning and evening home blood pressure measurements from the J-HOME study.

Obara T, Ito K, Ohkubo T, Shibamiya T, Shinki T, Nakashita M, Hara A, Metoki H, Inoue R, Asayama K, Kikuya M, Mano N, Imai Y; J-HOME Study Group.

Hypertens Res. 2009 Dec;32(12):1072-8. doi: 10.1038/hr.2009.152. Epub 2009 Sep 25.

PMID:
19779486
7.

Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.

Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.

EuroIntervention. 2012 Jan;7(9):1077-80. doi: 10.4244/EIJV7I9A171.

8.

[Epidemiological characteristics and clinical features of black African subject's resistant hypertension].

Yaméogo NV, Samadoulougou AK, Kagambèga LJ, Millogo GR, Yaméogo AA, Kologo KJ, Ilboudo E, Kaboré E, Mandi G, Kombasséré K, Toguyeni BJ, Pignatelli S, Simporé J, Zabsonré P.

Ann Cardiol Angeiol (Paris). 2014 Apr;63(2):83-8. doi: 10.1016/j.ancard.2014.01.002. Epub 2014 Jan 21. French.

PMID:
24492012
9.
10.
11.

Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.

Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.

Catheter Cardiovasc Interv. 2013 Feb;81(2):335-9. doi: 10.1002/ccd.24557. Epub 2012 Aug 13.

PMID:
22807098
12.

Efficacy and safety of renal denervation in elderly patients with resistant hypertension.

Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2015 Aug;86(2):299-303. doi: 10.1002/ccd.25166.

PMID:
23983010
13.
14.

Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study.

Campo C, Fernández G, González-Esteban J, Segura J, Ruilope LM; ESPADA Study Group.

Blood Press. 2000;9(6):355-62.

PMID:
11212065
15.

Non-pharmacological methods in the treatment of resistant hypertension.

Kichukov KN, Dimitrov HV, Nikolova LK, Petrov IS, Tokmakova MP.

Folia Med (Plovdiv). 2012 Apr-Jun;54(2):5-11. Review.

PMID:
23101278
16.

Catheter-based renal denervation for treatment of resistant hypertension.

Vase H, Mathiassen ON, Kaltoft A, Pedersen EB, Christensen KL, Buus NH, Lederballe O, Lassen JF, Bøtker HE, Thuesen L.

Dan Med J. 2012 Jun;59(6):A4439.

PMID:
22677237
17.

[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].

Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4. Chinese.

PMID:
15555399
18.

Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.

Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2014 Jan;30(1):16-21. doi: 10.1016/j.cjca.2013.07.008. Epub 2013 Oct 23. Review.

PMID:
24269056
19.

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators.

J Am Coll Cardiol. 2014 Sep 16;64(11):1071-8. doi: 10.1016/j.jacc.2014.05.012. Epub 2014 May 20.

20.

[Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].

Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):218-23. doi: 10.1016/j.ancard.2012.05.002. Epub 2012 May 23. French.

PMID:
22695025

Supplemental Content

Support Center